About Amgen
Countries

AMGEN: EMBRACING THE FUTURE
WITH A LEGACY IN BIOLOGICS

AMGEVITA®: A continuation of Amgen’s legacy in inflammatory disease

Amgen has nearly four decades of experience in developing and supplying innovator biologics dedicated to serving every patient every time. Amgen is committed to delivering high-value health solutions in inflammatory disease.1,2
Image showing Amgen's legacy in inflammatory disease.
About Amgen
Read more
*Marketed by Amgen in the US and Canada; by Pfizer in Europe.
Commercially available in the US from July 2019.
  1. Amgen Products. Available at: www.amgen.com/products/. Last accessed May 2020.
  2. Amgen Biosimilars. Available at: www.amgenbiosimilars.com. Last accessed May 2020.

The information contained in this website is for European healthcare professionals only

I understand and confirm I am an EU healthcare professional
Read more >
I am not an EU healthcare professional
Read more >
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.